
TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 20
IS  - S7
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.14385
DO  - doi:10.1111/codi.14385
SP  - 3
EP  - 12
PY  - 2018
ER  - 

AU  - Kamalov, German
AU  - Hummel, John D.
C7  - pp. 23-32
TI  - Equipment options for the ablation of atrial fibrillation
SN  - 9781118658505
UR  - https://doi.org/10.1002/9781118658369.ch04
DO  - doi:10.1002/9781118658369.ch04
SP  - 23-32
KW  - ablation generators
KW  - anesthesia
KW  - atrial fibrillation ablation
KW  - catheters
KW  - conscious sedation
KW  - electroanatomic mapping
KW  - EP recording systems
KW  - transesophageal echocardiography
KW  - transseptal puncture
KW  - X-ray equipment
PY  - 2018
AB  - Summary This chapter discusses the following equipment options for ablation of atrial fibrillation (AF): sedation, X-ray equipment and shielding, EP recording and pacing systems, equipment for transseptal puncture, echocardiography options, and catheters, ablation generators and electroanatomic mapping. Either general anesthesia or conscious sedation is used in electrophysiology laboratories performing catheter ablation of AF. The choice of sedation or general anesthesia is generally determined by physician preference, patient characteristics, and hospital resources, and this choice carries implications for equipment options that need to be available. Successful transseptal puncture is a crucial step in AF ablation and can be safely performed under fluoroscopy with or without intracardiac echocardiographic guidance. Transesophageal echocardiography (TEE) is most commonly used prior to the AF ablation procedure to rule out left atrial thrombus in patients prior to left atrial instrumentation. In some labs, TEE is utilized to facilitate transseptal catheterization.
ER  - 

TY  - JOUR
AU  - Kim, Sol
AU  - Williams, Drake W
AU  - Lee, Cindy
AU  - Kim, Terresa
AU  - Arai, Atsushi
AU  - Shi, Songtao
AU  - Li, Xinmin
AU  - Shin, Ki-Hyuk
AU  - Kang, Mo K
AU  - Park, No-Hee
AU  - Kim, Reuben H
TI  - IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 32
IS  - 2
SN  - 9781118658505
UR  - https://doi.org/10.1002/jbmr.2985
DO  - doi:10.1002/jbmr.2985
SP  - 309
EP  - 318
KW  - IL-36
KW  - OSTEONECROSIS OF THE JAW
KW  - BISPHOSPHONATE
KW  - COLLAGEN
KW  - TGF-β
KW  - Erk
PY  - 2017
AB  - ABSTRACT Long-term administration of nitrogen-containing bisphosphonates can induce detrimental side effects such as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in human. Although inflammation is known to be associated with BRONJ development, the detailed underlying mechanism remains unknown. Here, we report that the pro-inflammatory cytokine IL-36α is, in part, responsible for the BRONJ development. We found a notably higher level of IL-36α and lower level of collagen in the BRONJ lesions in mice. We also found that IL-36α remarkably suppressed TGF-?-mediated expression of Collα1 and α-Sma via the activation of Erk signaling pathway in mouse gingival mesenchymal stem cells. When IL-36 signaling was abrogated in vivo, development of BRONJ lesions was ameliorated in mice. Taken together, we showed the pathologic role of IL-36α in BRONJ development by inhibiting collagen expression and demonstrated that IL-36α could be a potential marker and a therapeutic target for the prevention and treatment of BRONJ. ? 2016 American Society for Bone and Mineral Research.
ER  - 

TY  - JOUR
TI  - Free Communications Sessions 01–16 Wednesday, August 28, 2013
JO  - International Dental Journal
JA  - Int Dent J
VL  - 63
IS  - s1
SN  - 9781118658505
UR  - https://doi.org/10.1111/idj.12049
DO  - doi:10.1111/idj.12049
SP  - 1
EP  - 98
PY  - 2013
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4–7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 9781118658505
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
AU  - Oakley, Carol
AU  - Larjava, Hannu
TI  - Hemostasis, coagulation, and complications
JO  - Endodontic Topics
JA  - Endod Topics
VL  - 24
IS  - 1
SN  - 9781118658505
UR  - https://doi.org/10.1111/etp.12011
DO  - doi:10.1111/etp.12011
SP  - 4
EP  - 25
PY  - 2011
AB  - Wounding always provokes bleeding that leads to a complicated process of hemostasis that stops the loss of blood and initiates the healing response in the tissue. In the primary hemostasis, vasoconstriction limits the blood loss and platelets stick to exposed collagen, become activated and aggregate to form the soft plug. The coagulation process that follows operates on different cell surfaces where extrinsic and intrinsic coagulation pathways operate in parallel leading to formation and stabilization of the fibrin clot. In this review, we will summarize the current understanding of the hemostasis process and coagulation and discuss the clinical issues involved in management of bleeding problems.
ER  - 

TY  - JOUR
TI  - American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting Abstracts Honolulu, Hawaii, October 28–31, 2015
JO  - Muscle & Nerve
JA  - Muscle Nerve
VL  - 52
IS  - S2
SN  - 9781118658505
UR  - https://doi.org/10.1002/mus.24891
DO  - doi:10.1002/mus.24891
SP  - S13
EP  - S144
PY  - 2015
ER  - 

TY  - JOUR
TI  - Free Communications Sessions 33–46 Friday, August 30, 2013
JO  - International Dental Journal
JA  - Int Dent J
VL  - 63
IS  - s1
SN  - 9781118658505
UR  - https://doi.org/10.1111/idj.12051
DO  - doi:10.1111/idj.12051
SP  - 198
EP  - 296
PY  - 2013
ER  - 

TY  - JOUR
AU  - Levi, Marcel
TI  - Current understanding of disseminated intravascular coagulation
JO  - British Journal of Haematology
VL  - 124
IS  - 5
SN  - 9781118658505
UR  - https://doi.org/10.1046/j.1365-2141.2003.04790.x
DO  - doi:10.1046/j.1365-2141.2003.04790.x
SP  - 567
EP  - 576
KW  - disseminated intravascular coagulation
KW  - tissue factor
KW  - cytokines
KW  - inflammation
KW  - protein C
PY  - 2004
ER  - 

TY  - JOUR
TI  - Aspen 6th Clinical Congress Proceedings
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 5
IS  - 6
SN  - 9781118658505
UR  - https://doi.org/10.1177/014860718100500619
DO  - doi:10.1177/014860718100500619
SP  - 552
EP  - 582
PY  - 1981
ER  - 

TY  - JOUR
TI  - Author Index
JO  - Clinical Oral Implants Research
JA  - Clin. Oral. Implants. Res.
VL  - 23
IS  - s7
SN  - 9781118658505
UR  - https://doi.org/10.1111/clr.12025
DO  - doi:10.1111/clr.12025
SP  - 262
EP  - 269
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - Vox Sanguinis
VL  - 99
IS  - s1
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1423-0410.2010.01343_2.x
DO  - doi:10.1111/j.1423-0410.2010.01343_2.x
SP  - 91
EP  - 516
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts of the Hemostasis & Thrombosis Research Society, 2011 Annual Scientific Symposium, April 28-30, Northwestern Memorial Hospital, Chicago, IL
JO  - Haemophilia
VL  - 17
IS  - 3
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1365-2516.2011.02551.x
DO  - doi:10.1111/j.1365-2516.2011.02551.x
SP  - 564
EP  - 569
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - HIV Medicine
VL  - 11
IS  - s1
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1468-1293.2010.00841_2.x
DO  - doi:10.1111/j.1468-1293.2010.00841_2.x
SP  - 19
EP  - 119
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 65
IS  - S10
SN  - 9781118658505
UR  - https://doi.org/10.1002/art.38216
DO  - doi:10.1002/art.38216
SP  - S1
EP  - S1331
PY  - 2013
ER  - 

TY  - JOUR
TI  - 10.30–12.30
JO  - BJU International
VL  - 94
IS  - s2
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1465-5101.2004.05078.x
DO  - doi:10.1111/j.1465-5101.2004.05078.x
SP  - 111
EP  - 133
PY  - 2004
ER  - 

TY  - JOUR
TI  - 22nd IEC Proceedings
JO  - Epilepsia
VL  - 38
IS  - s3
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1528-1157.1997.tb02952.x
DO  - doi:10.1111/j.1528-1157.1997.tb02952.x
SP  - 1
EP  - 284
PY  - 1997
ER  - 

TY  - JOUR
AU  - Hughes, Phillip F.
AU  - Carmichael, Eleanor M.
AU  - Cull, Anthony B.
TI  - Toxic Shock Syndrome Presenting to a Paediatric Service
JO  - Australian and New Zealand Journal of Obstetrics and Gynaecology
VL  - 25
IS  - 4
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1479-828X.1985.tb00749.x
DO  - doi:10.1111/j.1479-828X.1985.tb00749.x
SP  - 292
EP  - 295
PY  - 1985
AB  - Summary: A case of toxic shock syndrome occuring in a 13-year-old and presenting to a paediatric service is described. Some implications are discussed including an approach to menstrual protection and the question of future contraceptive needs.
ER  - 

TY  - JOUR
TI  - Tuesday, 26 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_2.x
DO  - doi:10.1111/j.1538-7836.2011.04380_2.x
SP  - 251
EP  - 498
PY  - 2011
ER  - 

TY  - JOUR
AU  - Beal, Matthew W.
AU  - Doherty, Arin M.
AU  - Curcio, Keith
TI  - Peliosis hepatis and hemoperitoneum in a dog with diphacinone intoxication
JO  - Journal of Veterinary Emergency and Critical Care
VL  - 18
IS  - 4
SN  - 9781118658505
UR  - https://doi.org/10.1111/j.1476-4431.2008.00322.x
DO  - doi:10.1111/j.1476-4431.2008.00322.x
SP  - 388
EP  - 392
KW  - anticoagulant rodenticide
KW  - Bartonella henselae
KW  - canine
KW  - liver
KW  - stoat
PY  - 2008
AB  - Abstract Objective: To describe the clinical course of a dog presented with peliosis hepatis and hemoperitoneum in concert with anticoagulant rodenticide intoxication. Case summary: A 7.75-year-old spayed female Shetland Sheepdog presented with clinical signs consistent with hypovolemia, hemoperitoneum, and a history of bright green stool 3 days before the onset of clinical signs. Initial packed cell volume/total solids were consistent with acute hemorrhage. A coagulation profile showed prolongation in activated clotting time and prolongation of both prothrombin and activated partial thromboplastin time, suggesting abnormal coagulation. Abdominal hemorrhage persisted in the face of normalization of the hemodynamic status and coagulation profile, and treatment with Vitamin K1. Abdominal ultrasound revealed multiple patchy hypoechoic areas throughout the caudate liver lobe. An exploratory laparotomy was performed 24 hours after presentation and revealed the caudate liver lobe as the source of the hemorrhage. Histopathologic examination of a specimen of the liver was consistent with peliosis hepatis. Toxicologic testing identified diphacinone levels in the blood consistent with anticoagulant rodenticide intoxication. Postoperative recovery was uneventful, and within 48 hours the dog was discharged. The dog returned to full function and a hepatic ultrasound performed 15 months postoperatively showed no significant abnormalities. New or unique information provided: Exposure to anticoagulant rodenticides may be associated with the development of peliosis hepatis in dogs.
ER  - 
